z-logo
Premium
Effect of mifepristone on the corpus luteum in early pregnancy
Author(s) -
Niinimäki M.,
Ruokonen A.,
Tapanainen J. S.,
Järvelä I. Y.
Publication year - 2009
Publication title -
ultrasound in obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.202
H-Index - 141
eISSN - 1469-0705
pISSN - 0960-7692
DOI - 10.1002/uog.6418
Subject(s) - mifepristone , corpus luteum , medicine , misoprostol , human chorionic gonadotropin , ovary , abortifacient , pregnancy , myometrium , medical abortion , hormone , endometrium , gynecology , endocrinology , obstetrics , uterus , abortion , biology , genetics
Objective The antiprogestin mifepristone is widely used for medical termination of pregnancy (TOP). Previous studies have suggested that the mechanism of mifepristone is based on its action in the endometrium and myometrium. The aim of this study was to evaluate the possible effects of mifepristone on corpus luteum activity. Methods This was a prospective, longitudinal controlled study to which 20 patients undergoing medical TOP (study group) and 20 patients with normal ongoing pregnancy (control group) were recruited. Medical TOP was induced with 200 mg of mifepristone followed by 0.8 mg of misoprostol 2 days later. Three‐dimensional ultrasound examinations and hormone assays (progesterone, human chorionic gonadotropin, and 17‐hydroxyprogesterone) were performed in both groups on the day of, and 2 days after, administration of mifepristone. Total volume (vascularized + non‐vascularized) of the dominant (containing corpus luteum) and non‐dominant ovary and serum hormone levels were measured. Results After administration of mifepristone, a decrease in serum progesterone levels was observed with a simultaneous decrease in the non‐vascularized volume of the dominant ovary in the study group. No such changes were observed in the control group. Conclusions The observations indicate that, in addition to trophoblastic tissue, the corpus luteum is also the target of mifepristone. Copyright © 2009 ISUOG. Published by John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here